Dr. Michael Wysota, MD

  • Philadelphia, PA
  • Hematologist and oncologist
NPI1619472594PAC ID5395280630
Medicare services, 2024
94
Medicare patients, 2024
38
Part D claims, 2024
138
Publications
4
Hospital affiliations
3
Practice address
111 South 11th Street, Philadelphia, PA 19107
Practice phone
Call (215) 955-6000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Thomas Jefferson University Hospital

Hospital · Philadelphia, Pennsylvania

See all 5 affiliations

Find Dr. Wysota's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Michael Wysota is a hematologist and oncologist in Philadelphia, Pennsylvania

Dr. Wysota practices at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Wysota's NPI, 1619472594, was assigned on March 24, 2018. Dr. Wysota holds Pennsylvania license MD485195.

NPI and contact details
Medicare PAC ID
5395280630
NPI enumeration date
March 24, 2018
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(215) 955-6000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
34
Medical school graduation
2018

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Michael Wysota practices at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania

Dr. Wysota's primary practice is Thomas Jefferson University Hospital, at 111 South 11th Street, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 955-6000.

Source: Dmand AI Affiliation Data

Dr. Michael Wysota is affiliated with 4 sites of care and 1 medical group

Dr. Wysota's primary practice is Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. Dr. Wysota is also affiliated with Jefferson Einstein Philadelphia Hospital. The medical group on file is Jefferson University Physicians. Dmand AI also links Dr. Wysota to 1 more hospital and 1 group practice or clinic, each named with a free account.

See all 5 affiliations for Dr. Wysota

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Michael Wysota's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wysota practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Thomas Jefferson University HospitalAvailable with a free account
+3 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Wysota practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Thomas Jefferson University and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Michael Wysota is one of 645 hematologists and oncologists in Pennsylvania

Hematology and oncology is Dr. Wysota's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Wysota is licensed in Pennsylvania.

Specialties and state licenses

  • Hematology and oncology, PennsylvaniaPrimaryLicense MD485195 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Wysota

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Michael Wysota billed Medicare for 94 services in 2024

CMS data shows 94 Medicare services from Dr. Wysota across 2 procedure codes in 2024, for 38 Medicare patients. Medicare paid $6,955 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 202494
Medicare patients38
Paid by Medicare$6,955
Procedure codes2

Dr. Wysota compared with the Pennsylvania median for hematologists and oncologists, 2024

  • Dr. Wysota
  • Pennsylvania median
Medicare services
94vs 65486% below
Medicare patients
38vs 22783% below
Part D claims
25vs 39394% below

Medians across 600 hematologists and oncologists in Pennsylvania with Dmand AI profiles that report each measure.

Dr. Wysota's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Wysota

Need commercial claims for Dr. Wysota?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Wysota and other hematologists and oncologists in Pennsylvania.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Michael Wysota treated 38 Medicare patients in 2024, average age 74

CMS counts 38 Medicare patients who saw Dr. Wysota in 2024. The largest group is 75 to 84, with 15 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 3.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wysota's median patient age at 67, with 42% women.

Medicare patients, 202438
Average age74
Average risk score3.20

Dr. Wysota's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Wysota's Medicare patients by sex, 2024

  • Women1745%
  • Men2155%

Chronic conditions among Dr. Wysota's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis74%
  4. Ischemic heart disease58%
  5. Chronic kidney disease50%
  6. Anxiety47%
  7. Heart failure47%
  8. COPD34%

Share of Medicare patients with each condition. A patient can have several.

Dr. Wysota's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 67

Patient panel by sex, all payers

  • Women42%
  • Men56%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Michael Wysota wrote 138 Medicare Part D claims in 2024

In 2024, Dr. Wysota wrote 138 Medicare Part D claims for 41 patients. 72% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $407 in total drug cost. In 2023, CMS named 110 claims across 6 drugs.

Part D claims, 2024138
Drugs named by CMS2
Total drug cost$407
Part D patients41

Dr. Wysota's Part D claims by kind of drug, 2024

  • Generic99 claims72%
  • Brand-name39 claims28%

Dr. Wysota's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1102024: 2577%

Drugs named by CMS: 2 in 2024, 6 in 2023.

See all prescribing by Dr. Wysota

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Michael Wysota offers telehealth to Medicare patients

Dr. Wysota accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wysota as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Wysota by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Michael Wysota has 4 publications on record

Dmand AI links 4 papers to Dr. Wysota, published from 2020 to 2022. Dr. Wysota's most frequent co-authors are Ana R. Acuna-Villaorduna, MD, Steven L. Allen, MD and Steven L. Allen.

Papers4
Years published2020 to 2022

Dr. Wysota's most frequent co-authors

Recent publications by Dr. Wysota

See all 4 publications and co-authors

See who Dr. Wysota researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Wysota works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Michael Wysota received $410 in industry payments in 2025

CMS Open Payments shows 6 general payments to Dr. Wysota from 4 drug and device companies in 2025. Education make up the largest share, 53% of the total. Abbvie Inc. paid the most, $220.

General payments to Dr. Wysota by kind, 2025 to 2025

$410in total
  • Education$21753%
  • Food and beverage$19247%

Companies that paid Dr. Wysota the most, 2025 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Wysota

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Michael Wysota's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Michael Wysota

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Michael Wysota's NPI number?

Dr. Michael Wysota's NPI number is 1619472594. It was assigned on March 24, 2018, and it is active in the NPI Registry.

What kind of doctor is Dr. Michael Wysota?

Dr. Michael Wysota is a hematologist and oncologist in Philadelphia, Pennsylvania. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Michael Wysota practice?

Dr. Wysota practices at 111 South 11th Street, Philadelphia, PA 19107. Dr. Wysota's primary practice is Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. Dmand AI also links Dr. Wysota to 1 hospital and 1 group practice or clinic.

What is Dr. Michael Wysota's office phone number?

The practice phone on file for Dr. Wysota is (215) 955-6000.

What is Dr. Michael Wysota's medical license number?

Dr. Wysota holds Pennsylvania license MD485195.

Which hospitals is Dr. Michael Wysota affiliated with?

Dr. Wysota practices at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania. Dr. Wysota is also affiliated with Jefferson Einstein Philadelphia Hospital. Dmand AI links Dr. Wysota to 1 more hospital.

What medical group is Dr. Michael Wysota part of?

Dr. Wysota is linked to Jefferson University Physicians.

Does Dr. Michael Wysota accept Medicare?

Yes. CMS data shows Dr. Wysota billed Medicare for 94 services in 2024, and Dr. Wysota accepts Medicare assignment.

Does Dr. Michael Wysota offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Wysota as offering telehealth services.

How many Medicare patients does Dr. Michael Wysota see?

CMS counts 38 Medicare patients who saw Dr. Wysota in 2024, with an average age of 74.

Show 6 more questionsShow fewer questions

What services does Dr. Michael Wysota bill to Medicare?

In 2024, Dr. Wysota's most billed Medicare services were hospital inpatient care (99232) and hospital inpatient care (99223).

What drugs does Dr. Michael Wysota prescribe most?

In 2024 Medicare Part D data, Dr. Wysota's most prescribed drugs by claims were Valacyclovir and Mirtazapine.

Has Dr. Michael Wysota received payments from drug or device companies?

CMS Open Payments shows $410 in general payments to Dr. Wysota from 4 companies from 2025 to 2025. The largest total came from Abbvie Inc.

How long has Dr. Michael Wysota been practicing?

Dr. Wysota graduated from medical school in 2018, 8 years ago.

Does Dr. Michael Wysota do research?

Dmand AI links 4 publications to Dr. Wysota, published from 2020 to 2022.

Who does Dr. Michael Wysota publish with?

Dr. Wysota's most frequent co-authors are Ana R. Acuna-Villaorduna, MD (1 shared paper), Steven L. Allen, MD (1 shared paper) and Steven L. Allen (1 shared paper).

Selling to hematology and oncology practices?

See hematologists and oncologists in Pennsylvania by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)